Glaukos
Breakthrough products and procedures to transform the treatment of glaucoma, one of the world’s leading causes of blindness. Learn more
Launch date
Employees
Market cap
CAD9.5b
Enterprise valuation
CAD9.3b (Public information from Sep 2024)
Share price
$130.07001 GKOS
Aliso Viejo California (HQ)
Authorizing premium user...